Prescribing Zinc Oxide for Incontinence-Related Skin Protection
Prescribe topical zinc oxide 20% cream or ointment to be applied liberally to clean, dry perianal and perineal skin after each incontinence episode or at minimum 2-3 times daily, creating a visible protective barrier layer. 1
Application Protocol
The FDA-approved indication for zinc oxide 20% specifically includes protecting skin from wetness and treating/preventing diaper rash, which directly applies to incontinence-associated dermatitis (IAD) 1. Here's how to prescribe it effectively:
Step-by-Step Instructions for Patients:
Cleanse the skin - Use a pH-balanced, no-rinse skin cleanser rather than soap and water (soap disrupts skin pH and may worsen IAD risk) 2, 3
Pat dry thoroughly - Ensure skin is completely dry before application
Apply zinc oxide liberally - Use enough to create a visible white protective layer over all at-risk areas (perianal, perineal, buttocks, inner thighs)
Reapply after each incontinence episode - The barrier must be maintained continuously
For enhanced protection, apply petroleum jelly OVER the zinc oxide layer (not mixed together) - this sequential application showed superior results in preventing IAD compared to mixing products together 2
Evidence-Based Rationale
The combination approach (cleanser + zinc oxide + petroleum jelly applied sequentially) demonstrated the best outcomes in a 2024 pilot study, showing decreased IAD severity, improved skin pH to mild acidity, and increased skin moisture 2. This layering technique outperformed mixing the products together.
While a 2021 study suggested silicone dressings may have superior therapeutic effects for established IAD 4, zinc oxide remains the most accessible, cost-effective first-line barrier protection that primary care physicians can prescribe 1.
Clinical Considerations
Common pitfall: Many clinicians prescribe zinc oxide to be applied "as needed" - this is insufficient. The barrier must be maintained continuously, requiring reapplication after each cleansing or incontinence episode 2.
Product selection: Prescribe zinc oxide 20% concentration specifically - this is the FDA-approved strength for skin protection 1. Lower concentrations may be less effective.
Monitoring: Assess skin condition within 7 days. If IAD develops despite proper barrier use, consider escalating to specialized skin protectants containing acrylic terpolymer or silicone-based products 5.
Prescription Example
"Zinc oxide 20% ointment - Apply liberally to perianal and perineal skin after cleansing and drying, minimum 2-3 times daily and after each incontinence episode. May apply petroleum jelly over zinc oxide layer for enhanced protection. Dispense: 4 oz tube, refills as needed."
The evidence shows this approach can prevent IAD development and maintain skin integrity when applied consistently 2, 3, 5, though the overall certainty of evidence remains low due to small study sizes and heterogeneity 3.